Dan-Andrei Waitman, MD, MPH

home / authors / dan-andrei-waitman-md-mph

Articles

August 6th 2013

A Natural Experiment in Mass Media Modulated Pharmacokinetics After a Change in Tablet Formulation

Natan R. Kahan, PhD, RPh, MHA Daniel A. Vardy, MD, MSc Dan-Andrei Waitman, MD, MPH Gherta Brill, MD

Sporadic, unsubstantiated side effects were reported in the mass media after a formulation change of levothyroxine tablets induced patients to monitor thyroid-stimulating hormone levels and to unnecessarily stop taking medication.

September 7th 2009

Prior Authorization to Improve Testing of Glycosylated Hemoglobin in a Managed Care Setting

Natan R. Kahan, PhD, RPh, MHA Dan-Andrei Waitman, MD, MPH Shimon Blackman, BS (Pharm) Daniel A. Vardy, MD, MSc

Prior authorization was successfully implemented in a managed care setting to obtain 100.0% performance of A1C testing in patients with diabetes treated with expensive drugs.

March 16th 2009

Curtailing Laboratory Test Ordering in a Managed Care Setting Through Redesign of a Computerized Order Form

Natan R. Kahan, RPh, MHA Dan-Andrei Waitman, MD, MPH Daniel A. Vardy, MD, MSc

Simple restructuring of a computerized order form significantly reduced the number of laboratory tests suspected of being unnecessary or redundant.

September 1st 2005

Teaching Evidence-based Medicine in a Managed Care Setting: From Didactic Exercise to Pharmacopolicy Development Tool

Natan R. Kahan, RPh, MHA Yaakov Fogelman, MD Dan-Andrei Waitman, MD, MPH Ernesto Kahan, MD, MPH Avihu Bar-Yochai, MD Avraham Meidan, MD Eliezer Kitai, MD